Company intelligence / Profile preview

Coviguard

Mumbai, Maharashtra, India

Ownership: Private
Development stage: Other

Overview

Coviguard Healthcare is a pharmaceutical company based in India that specializes in the manufacturing and distribution of therapeutic solutions, with a significant focus on treatments for viral infections. The company gained prominence during the COVID-19 pandemic by providing essential medications such as Remdesivir and Favipiravir under its own brand names. Coviguard Healthcare operates primarily as a specialty pharmaceutical entity, ensuring the availability of critical care medicines in the Indian market. Its business model encompasses the production of high-quality generic formulations and the management of a robust supply chain for healthcare providers.

Therapeutic areas: Infectious Diseases
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Coviguard.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Coviguard.

Explore the full profile